Quick-Neuron™ Cholinergic – Maintenance Medium
Quick-Neuron™ Cholinergic – Maintenance Medium is formulated for long-term maintenance of human iPSC-derived cholinergic neurons in vitro. Designed for research use, this medium supports consistent culture performance for downstream neuroscience and pharmacology applications.
$220.00
Product Specifications
| Parameters | Specifications |
|---|---|
| Product Name | Quick-Neuron™ Cholinergic – Maintenance Medium |
| Catalog No. | CH-MM |
| Product Components | Component N1, Component B, and Component P |
| Storage Conditions | All components can be stored at -20°C or -80°C. |
| Cell Type | Cholinergic Neurons |
| Shelf Life | 1 Year |
| Sterility | No growth observed for Bacteria and Fungus |
| Mycoplasma | No contamination detected |
| Restricted Use | For research use only. Not for use in diagnostic or therapeutic procedures. |
Cholinergic Neuron Resources
Quick-Neuron™ Cholinergic – Human iPSC-Derived Neurons
Quick-Neuron™ Cholinergic – SeV Kit
Induction of specific neuron types by overexpression of single transcription factors.
Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons
Tools to Study Neurodegeneration: iPSC-derived Neurons, Nerve Organoids, and Synaptogenic Beads
No results found.
Related Products
FAQs
Do I need a license agreement for any of Ricoh Biosciences’ products?
No. You don’t need any licence or material transfer agreement (MTA) to use our differentiation kits or iPSC-derived cells. However, please be advised that these products are for research use only.
What kind of transcription factors are used for differentiation induction?
It is a proprietary formulated RNA and cannot be disclosed.
Does Quick-Tissue™ technology leave a genetic footprint?
Sendai virus (SeV) is an RNA virus, so it does not integrate into the genomic DNA. In principle, a foreign gene introduced intracellularly in the form of RNA is quickly translated and expressed because, unlike DNA, RNA does not need to enter the nucleus for forced expression, thereby providing no chance of mutagenesis. This is discussed in the following review paper: Yamamoto, et al., (2009) “Current prospects for mRNA gene delivery.” Eur. J. Pharm Biopharm 71, 484-489.
Will SeV remain active after differentiation?
No. The SeV used in our kits is a temperature-sensitive mutant that is active at 33℃ but becomes inactive at 37℃, which is the temperature instructed in the user guides post-differentiation.
No results found.